IRON
IRON
NASDAQ · Biotechnology

Disc Medicine Inc

$59.11
+0.94 (+1.62%)
Analyst Consensus
Strong Buy
19
Analysts
High
Coverage
Buy 18 95%
Hold 1 5%
Sell 0 0%
Price Target
Analyst Price Target -62.0% upside
Low Target $15.33
Average Target $22.47
High Target $35.88
Current Price $59.11
Current
$59.11
Target
$22.47
$15.33 $22.47 avg $35.88
Scenario Analysis
Bear Case
$15.33
-74.1%
Low target
Base Case
$22.47
-62.0%
Avg target
Bull Case
$35.88
+-39.3%
High target
Risk/Reward
0.5x
Unfavorable
Price in Context
52-Week High
$99.50
-40.6% from high
52-Week Low
$30.82
+91.8% from low
50-Day SMA
$78.91
-25.1% vs SMA
200-Day SMA
$68.08
-13.2% vs SMA
RSI (14)
34.9
Neutral
Target vs 52W High
$22.47
-77.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +24.6%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.2%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +161.7%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -2.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -89.8%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.6%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -3.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -27.6%